BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7949710)

  • 1. Local delivery of an antiproliferative drug with use of hydrogel-coated angioplasty balloons.
    Consigny PM; Barry JJ; Vitali NJ
    J Vasc Interv Radiol; 1994; 5(4):553-60. PubMed ID: 7949710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons.
    Azrin MA; Mitchel JF; Fram DB; Pedersen CA; Cartun RW; Barry JJ; Bow LM; Waters DD; McKay RG
    Circulation; 1994 Jul; 90(1):433-41. PubMed ID: 8026030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of nadroparin via hydrogel-coated angioplasty balloon: effect on platelet deposition and smooth muscle cell proliferation--an experimental study.
    Johnson MS; Bergmann CA; Carmody TJ; Dreesen RG; Barry JJ; Barina C; Orazi A; Ambrosius WT
    J Vasc Interv Radiol; 2000 Jan; 11(1):115-22. PubMed ID: 10693723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons.
    Mitchel JF; Azrin MA; Fram DB; Hong MK; Wong SC; Barry JJ; Bow LM; Curley TM; Kiernan FJ; Waters DD
    Circulation; 1994 Oct; 90(4):1979-88. PubMed ID: 7923688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
    Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
    Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
    Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
    Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model.
    Gottsauner-Wolf M; Jang Y; Lincoff AM; Cohen JL; Labhasetwar V; Poptic EJ; Forudi F; Guzman LA; DiCorleto PE; Levy RJ; Topol EJ; Ellis SG
    Am Heart J; 1997 Mar; 133(3):329-34. PubMed ID: 9060802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mural delivery of iloprost with use of hydrogel-coated balloon catheters suppresses local platelet aggregation.
    Kandarpa K; Nakatsuka S; Bravo SM; Harapanhalli RS; Barry JJ
    J Vasc Interv Radiol; 1997; 8(6):997-1004. PubMed ID: 9399469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion.
    Fram DB; Aretz T; Azrin MA; Mitchel JF; Samady H; Gillam LD; Sahatjian R; Waters D; McKay RG
    J Am Coll Cardiol; 1994 Jun; 23(7):1570-7. PubMed ID: 8195516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific intracoronary thrombolysis with urokinase-coated hydrogel balloons: acute and follow-up studies in 95 patients.
    Glazier JJ; Hirst JA; Kiernan FJ; Fram DB; Eldin AM; Primiano CA; Mitchel JF; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):246-53. PubMed ID: 9213022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran sulfate as a drug delivery platform for drug-coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response.
    Lamichhane S; Anderson J; Remund T; Kelly P; Mani G
    J Biomed Mater Res B Appl Biomater; 2016 Oct; 104(7):1416-30. PubMed ID: 26227252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis.
    Nunes GL; Hanson SR; King SB; Sahatjian RA; Scott NA
    J Am Coll Cardiol; 1994 Jun; 23(7):1578-83. PubMed ID: 8195517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific delivery of iloprost during experimental angioplasty suppresses smooth muscle cell proliferation.
    Kandarpa K; Nakatsuka S; Yousuf N; Barry JJ
    J Vasc Interv Radiol; 1998; 9(3):487-93. PubMed ID: 9618111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase inhibitors inhibit both proliferation and chemotaxis of vascular smooth muscle cells.
    Shimokado K; Yokota T; Kosaka C; Zen K; Sasaguri T; Masuda J; Ogata J
    Ann N Y Acad Sci; 1995 Jan; 748():171-5; discussion 175-6. PubMed ID: 7695163
    [No Abstract]   [Full Text] [Related]  

  • 15. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
    Sauro MD; Thomas B
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, in vitro drug release, and cellular interactions of tailored paclitaxel releasing polyethylene oxide films for drug-coated balloons.
    Anderson JA; Lamichhane S; Remund T; Kelly P; Mani G
    Acta Biomater; 2016 Jan; 29():333-351. PubMed ID: 26432441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery.
    Miao RQ; Murakami H; Song Q; Chao L; Chao J
    Circ Res; 2000 Mar; 86(4):418-24. PubMed ID: 10700446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.
    Erlinge D; Heilig M; Edvinsson L
    Br J Pharmacol; 1996 Jun; 118(4):1028-34. PubMed ID: 8799578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of horseradish peroxidase delivery into the arterial wall in vivo as a model of local drug treatment: comparison between a porous and a gel-coated balloon catheter.
    Dick A; Kromen W; Jüngling E; Grosskortenhaus S; Kammermeier H; Vorwerk D; Günther RW
    Cardiovasc Intervent Radiol; 1999; 22(5):389-93. PubMed ID: 10501891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon.
    Riessen R; Rahimizadeh H; Blessing E; Takeshita S; Barry JJ; Isner JM
    Hum Gene Ther; 1993 Dec; 4(6):749-58. PubMed ID: 8186290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.